Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to -$890536.0.

  • Cumberland Pharmaceuticals' Net Cash Flow fell 79406.12% to -$890536.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.3 million, marking a year-over-year decrease of 11740.65%. This contributed to the annual value of -$357440.0 for FY2024, which is 7511.46% up from last year.
  • Cumberland Pharmaceuticals' Net Cash Flow amounted to -$890536.0 in Q3 2025, which was down 79406.12% from $978868.0 recorded in Q2 2025.
  • Cumberland Pharmaceuticals' Net Cash Flow's 5-year high stood at $1.9 million during Q2 2023, with a 5-year trough of -$9.8 million in Q1 2022.
  • Over the past 5 years, Cumberland Pharmaceuticals' median Net Cash Flow value was $216432.0 (recorded in 2022), while the average stood at -$503002.7.
  • Over the last 5 years, Cumberland Pharmaceuticals' Net Cash Flow had its largest YoY gain of 66690.44% in 2022, and its largest YoY loss of 587903.91% in 2022.
  • Cumberland Pharmaceuticals' Net Cash Flow (Quarter) stood at $1.2 million in 2021, then plummeted by 81.93% to $216432.0 in 2022, then plummeted by 186.1% to -$186341.0 in 2023, then surged by 368.02% to $499430.0 in 2024, then plummeted by 278.31% to -$890536.0 in 2025.
  • Its Net Cash Flow was -$890536.0 in Q3 2025, compared to $978868.0 in Q2 2025 and -$2.9 million in Q1 2025.